Logo image of MIM.CA

MIMEDIA HOLDINGS INC (MIM.CA) Stock Fundamental Analysis

TSX-V:MIM - TSX Venture Exchange - CA60250B1067 - Common Stock - Currency: CAD

0.52  +0.02 (+4%)

Fundamental Rating

0

Overall MIM gets a fundamental rating of 0 out of 10. We evaluated MIM against 66 industry peers in the Software industry. MIM has a bad profitability rating. Also its financial health evaluation is rather negative. MIM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MIM has reported negative net income.
MIM.CA Yearly Net Income VS EBIT VS OCF VS FCFMIM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

MIM has a Return On Assets of -546.65%. This is amonst the worse of the industry: MIM underperforms 92.54% of its industry peers.
Industry RankSector Rank
ROA -546.65%
ROE N/A
ROIC N/A
ROA(3y)-222.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIM.CA Yearly ROA, ROE, ROICMIM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

MIM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MIM.CA Yearly Profit, Operating, Gross MarginsMIM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -10K -20K -30K

More info and screens

0

2. Health

2.1 Basic Checks

MIM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MIM has been increased compared to 1 year ago.
The debt/assets ratio for MIM is higher compared to a year ago.
MIM.CA Yearly Shares OutstandingMIM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
MIM.CA Yearly Total Debt VS Total AssetsMIM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

MIM has an Altman-Z score of -147.46. This is a bad value and indicates that MIM is not financially healthy and even has some risk of bankruptcy.
MIM has a worse Altman-Z score (-147.46) than 89.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -147.46
ROIC/WACCN/A
WACC12.49%
MIM.CA Yearly LT Debt VS Equity VS FCFMIM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M

2.3 Liquidity

MIM has a Current Ratio of 0.54. This is a bad value and indicates that MIM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.54, MIM is doing worse than 68.66% of the companies in the same industry.
MIM has a Quick Ratio of 0.54. This is a bad value and indicates that MIM is not financially healthy enough and could expect problems in meeting its short term obligations.
MIM has a worse Quick ratio (0.54) than 68.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
MIM.CA Yearly Current Assets VS Current LiabilitesMIM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.78% over the past year.
MIM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.50%.
Measured over the past years, MIM shows a very negative growth in Revenue. The Revenue has been decreasing by -28.21% on average per year.
EPS 1Y (TTM)39.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-44.5%
Revenue growth 3Y-28.21%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIM.CA Yearly Revenue VS EstimatesMIM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 5K 10K 15K 20K 25K
MIM.CA Yearly EPS VS EstimatesMIM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MIM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MIM.CA Price Earnings VS Forward Price EarningsMIM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MIM.CA Per share dataMIM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MIM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MIMEDIA HOLDINGS INC

TSX-V:MIM (3/7/2025, 7:00:00 PM)

0.52

+0.02 (+4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.67%
Ins Owner ChangeN/A
Market Cap27.57M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2434.16
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -546.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-222.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -147.46
F-ScoreN/A
WACC12.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.5%
Revenue growth 3Y-28.21%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.79%
OCF growth 3YN/A
OCF growth 5YN/A